Washington turmoil is proving a bitter pill for Pfizer
Pharma giant facing into expiry of key patents and investors are becoming itchy
Pharma giant facing into expiry of key patents and investors are becoming itchy
Fear of overpaying cools mergers and acquisitions activity to $753 billion in quarter
Company’s shares down 1.3% in premarket trading after it says it will not separate
Irish shares fare better than wider European market, with Kingspan’s 7% rise leading way
Sanofi, Merck, Celgene and Gilead Sciences also believed to have been interested in firm
French pharma firm courts cancer group Medivation as key drugs face generics
French drugmaker’s advances have been rebuffed
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices